ERAS Sale Disclosure
Scott A Kupor · Executive branch OGE 278-T · Filed Sep 30, 2026
Sale
Reported value range
$1K - $15K
Scott A Kupor
Executive branch official
ERAS
Erasca
ERAS
Transaction date
Jul 30, 2026
Public filing date
Sep 30, 2026
Filing lag
Filed 62 days later
ERAS daily price context
Close on/before transaction
$18.68
Jul 30, 2026
First close after public filing
$14.58
Oct 1, 2026
Return after filing · so far
+9.95%
Through Oct 9, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Erasca Inc. Common Stock (ERAS)
- Quantity / price
- Not reported
- Transaction code
- S
- Form
- 278T
- Filing identifier
- oge_278t:B157175D415FEC4685258E82002DBEBE:1
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
2
Estimated value
$16K
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Erasca Inc. Common Stock (ERAS) ERAS Current | Sale | Jul 30, 2026 | $1K - $15K |
| Revolution Medicines Inc. Common Stock (RVMD) RVMD | Sale | Jul 30, 2026 | $1K - $15K |